• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WRIGHTS LANE SYNTHES USA PRODUCTS LLC 9MM TI CANNULATED HUMERAL NAIL-EX/240MM-STERILE; NAIL,FIXATION,BONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WRIGHTS LANE SYNTHES USA PRODUCTS LLC 9MM TI CANNULATED HUMERAL NAIL-EX/240MM-STERILE; NAIL,FIXATION,BONE Back to Search Results
Model Number 04.001.428S
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Nonunion/Delayed-union Bone Fracture (2369)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device was received, the investigation is in progress, no conclusion could be drawn at the time of filing this report.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event or Problem Description
It was reported that on (b)(6) 2019, patient underwent removal of titanium cannulated humeral nail ex, titanium locking screw 30 mm and titanium locking screw 38 mm.Implants were removed due to humeral shaft non-union.The patient originally had the humeral nail construct implanted to treat his humerus fracture on an unknown date.Patient was revised to a 9 hole 4.5 mm lcp broad plate and eight (8) 4.5 mm cortex screws.The surgery was successfully completed without delay.This is report 1 of 3 for (b)(4).
 
Additional Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Visual inspection: 9mm ti cannulated humeral nail-ex/240mm-sterile was received at cq.Upon visual inspection, it is observed that the device shows some discoloration, scratches, and deformation which may have occurred during explantation.No device problem was found.Mre review: this lot met all dimensional, visual, sterility and packaging criteria at the time of release with no issues documented during the manufacture that would contribute to this complaint condition.Investigation conclusion: visual inspection, and document specification review of the received device was performed at cq.The complaint condition cannot be confirmed with the information available.A definitive root cause could not be determined.During the investigation no unidentified product design/manufacturing issues or discrepancies were observed that may have contributed to the complaint condition.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post market safety surveillance activities.Manufacturing location: monument manufacturing date: 26-may-2017, expiration date: 30-apr-2026, part number: 04.001.428s, 9mm ti cannulated humeral nail-ex/240mm-sterile, lot number: h374525 (sterile), lot quantity: 6.Work order traveler met all inspection acceptance criteria.Inspection sheet, in-process acceptance, 4001ipa218 rev e met all inspection acceptance criteria.Inspection sheet, inspect dimensional 4001id418, rev f met all inspection acceptance criteria.Inspection sheet, final inspection, 4001fi418, rev d met all inspection acceptance criteria.Packaging label log lppf, lmd/lpf rev h was reviewed and determined to be conforming.Packaging bom was reviewed and found to be conforming with no deviations to normal packaging identified.Scn 13775 supplied by ethicon (abq) was reviewed and determined to be conforming.This lot met all dimensional, visual, sterility and packaging criteria at the time of release with no issues documented during the manufacture that would contribute to this complaint condition.This lot met all dimensional, visual, sterility and packaging criteria at the time of release with no issues documented during the manufacture that would contribute to this complaint condition.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
9MM TI CANNULATED HUMERAL NAIL-EX/240MM-STERILE
Common Device Name
NAIL,FIXATION,BONE
Manufacturer (Section D)
WRIGHTS LANE SYNTHES USA PRODUCTS LLC
1302 wrights lane east
west chester PA 19380
MDR Report Key8671461
Report Number2939274-2019-58488
Device Sequence Number2182842
Product Code JDS
UDI-Device Identifier10886982081056
UDI-Public(01)10886982081056
Combination Product (Y/N)N
Initial Reporter StateNC
Initial Reporter CountryUS
PMA/510(K) Number
K033071
Number of Events Summarized1
Summary Report (Y/N)N
Device Explanted Year2019
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 05/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date04/30/2026
Device Model Number04.001.428S
Device Catalogue Number04.001.428S
Device Lot NumberH374525
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/21/2019
Initial Date Received by Manufacturer 05/08/2019
Supplement Date Received by Manufacturer06/19/2019
Initial Report FDA Received Date06/05/2019
Supplement Report FDA Received Date06/27/2019
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-